Author:
Shinozaki Shohei,Watanabe Asuka,Kimata Masahiro,Miyazaki Makoto,Maekawa Shinichiroh
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. World Health Organization. Press briefing on WHO Mission to China and novel coronavirus outbreak. https://www.who.int/director-general/speeches/detail/press-briefing-on-who-mission-to-china-and-novel-coronavirus-outbreak. Accessed 10 Jun 2023.
2. Yoon J-J, Toots M, Lee S, et al. Orally efficacious broad-spectrum ribonucleoside analog inhibitor of influenza and respiratory syncytial viruses. Antimicrob Agents Chemother. 2018;62(8):e00766-e818.
3. Cox RM, Wolf JD, Plemper RK. Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets. Nat Microbiol. 2021;6(1):11–8.
4. Sheahan TP, Sims AC, Zhou S, et al. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci Transl Med. 2020;12(541):eabb5883.
5. Wahl A, Gralinski LE, Johnson CE, et al. SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801. Nature. 2021;591(7850):451–7.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献